ArticleAntibody therapeutics2026

Cytotoxic activity and safety characterization of IMV-M™, a MUC16 × DR5 bispecific antibody.

Victor S Goldmacher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.